The largest database of trusted experimental protocols

4 protocols using anti cd3

1

T-cell Activation and LPS Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were isolated from dissected spleen of adult (6 to 10 weeks old) male BALB/c mice (Jackson Laboratory, Bar Harbor, ME) euthanized with CO2. For T-cell activation, the splenocytes (2.5 × 105 cells/well) were incubated with RMPI 1640 medium (Gibco) containing 5% FBS in the 96-well plates coated with anti-CD3 (Corning) [23 (link)] for 6 or 18 hours (hrs) with or without EVs. For LPS stimulation, splenocytes (5 × 105 cells/well; 96 wells) were incubated with RMPI 1640 medium containing 5% FBS and 50 ng/ml LPS (Sigma, Saint Louis, MO) for 4 or 18 hrs with or without EVs. After stimulation, cell-free conditioned media were harvested to measure cytokine levels.
+ Open protocol
+ Expand
2

Evaluating CD8+ T Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse CD8+ T cells were stained with carboxyfluorescein diacetate succinimidyl ester (CFSE; 423801, BioLegend) according to the manufacturer’s instruction. Then, CD8+ T cells (1 × 105 per well) were cocultured with leukemia cells at a 16:1 ratio for 3 days or IMs at a 1:1 ratio for 5 days in 96-well plates coated with anti-CD3 (354720, Corning) in RPMI 1640 medium containing 10% FBS. The percentages of proliferating CD8+ T cells were determined by CFSE dilution. In some experiments, Dox (1 μg/ml); a nitric oxide synthase inhibitor, L-NMMA (0.5 mM); or an arginase inhibitor, nor-NOHA (0.5 mM) was added (see Fig. 4). Human T cells (1 × 105 per well) were stimulated with anti-CD3/CD28–coated beads (130-091-441, Miltenyi Biotec) and cocultured with human IMs sorted from the same donors at a 1:1 ratio in 96-well plates for 3 days. Then, the harvested cells were analyzed by flow cytometry.
+ Open protocol
+ Expand
3

Lymph Node Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 30 days of treatment, the lymph nodes were removed and macerated. Cell suspensions were washed and re-suspended in complete RPMI-1640 (Sigma; supplemented with 5% of fetal bovine serum, 40 μg/ml of gentamicin, 20 mM Hepes).
In these tests, preparations of whole cell from organs were used. Cell suspensions containing 5 × 106 cells in 200 μl were incubated in the presence or absence of OVA grade III – Sigma (200 μg/ml) or anti-CD3 (10 μl/ml) in 96 well, flat bottom (Costar 3595, Coming, NY, USA). Cells were cultured for 72 h at 37°C in an oven containing 5% CO2, and 18 h before the end of the culture, cells were incubated with [3 H] thymidine at a concentration of 0.25 μCi/well. Cells were collected in cells collector (Inotech cell Harvester, USA). Reading was held in a β-scintillation counter (Beckman, Brea, CA, USA). Posteriorly, the supernatants were collected and frozen at 20°C for subsequent measurement of the cytokines IL-5 and IFN-γ by ELISA.
+ Open protocol
+ Expand
4

NFkB-Luciferase Jurkat Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in-house engineered Jurkat/hOX40 cells, were stably transfected to generate a stable cell line that co-expressed an NFkB-luciferase reporter plasmid, pGL4.10[luc2] (Promega). Bright-Glo luciferase reagent and a luminometer were used to assess activation of NFkB signaling. The expression vector, luciferase reagent, and luminometer (Promega) were used according to manufacturer guidelines. Briefly, anti-CD3 (OKT3, at 1 μg/mL) was diluted in PBS and used to coat white 96-well plates (Costar) over night at 4 °C. The next morning, plates were washed to remove unbound anti-CD3 and 10,000 Jurkat/hOX40/NFkB-luciferase cells were plated in each well with 2 μg/mL functional grade CD28 (eBiosciences), +/− the ARC or other test agents. Plates were incubated at 37 °C/5% CO2 for 6 h, where after the Bright-Glo reagent was added and luminescence was assessed on a luminometer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!